Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Application
1.1.2 End-use
1.1.3 Regional scope
1.1.4 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in Middle East and Africa
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
Chapter 2 Executive Summary
Chapter 3 Digital Therapeutics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing smartphone penetration
3.3.1.2 Cost-effectiveness of digital health technology for providers and patients
3.3.1.3 Increasing demand for integrated healthcare systems and patient-centric care
3.3.2 Market restrain analysis
3.3.2.1 Reimbursement scenario
3.4 Digital Therapeutics: Market Analysis Tools: Porter’s Analysis
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Threat Of Substitutes
3.4.1.4 Threat Of New Entrants
3.4.1.5 Competitive Rivalry: Moderate
3.4.2 Digital Therapeutics Market: PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Economic Landscape
3.4.2.3 Social Landscape
3.4.2.4 Technological Landscape
3.4.2.5 Environmental Landscape
3.4.2.6 Legal Landscape
Chapter 4 Digital Therapeutics Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)
4.1 Segment Dashboard
4.2 Global Digital Therapeutics Market, by Application, 2016 to 2028
4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2028
4.3.1 Diabetes
4.3.1.1 Diabetes market, 2016 - 2028 (USD Million)
4.3.2 Obesity
4.3.2.1 Obesity market, 2016 - 2028 (USD Million)
4.3.3 Cardiovascular Diseases (CVD)
4.3.3.1 CVD market, 2016 - 2028 (USD Million)
4.3.4 Central Nervous System (CNS) Disease
4.3.4.1 CNS diseases market, 2016 - 2028 (USD Million)
4.3.5 Respiratory Diseases
4.3.5.1 Respiratory diseases market, 2016 - 2028 (USD Million)
4.3.6 Smoking Cessation
4.3.6.1 Smoking cessation market, 2016 - 2028 (USD Million)
4.3.7 Others
4.3.7.1 Others market, 2016 - 2028 (USD Million)
Chapter 5 Digital Therapeutics Market: Segment Analysis, By End Use, 2016 - 2028 (USD Million)
5.1 Segment Dashboard
5.2 Global Digital Therapeutics Market, by End Use, 2016 to 2028
5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.3.1 Patients
5.3.1.1 Patients market, 2016 - 2028 (USD Million)
5.3.2 Providers
5.3.2.1 Providers market, 2016 - 2028 (USD Million)
5.3.3 Payers
5.3.3.1 Payers market, 2016 - 2028 (USD Million)
5.3.4 Employers
5.3.4.1 Employers market, 2016 - 2028 (USD Million)
5.3.5 Others
5.3.5.1 Others market, 2016 - 2028 (USD Million)
Chapter 6 Global Digital Therapeutics Market: Regional Estimates & Trend Analysis, By Application, and By End Use
6.1 Global Digital Therapeutics Market: Regional Movement Analysis
6.2 North America
6.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.2.2 U.S.
6.2.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.2.3 Canada
6.2.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.3 Europe
6.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.2 U.K.
6.3.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.3 Germany
6.3.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.4 France
6.3.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.5 Italy
6.3.5.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.3.6 Spain
6.3.6.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.2 Japan
6.4.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.3 China
6.4.3.1. Market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.4 India
6.4.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.5 Latin America
6.5.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.2 Brazil
6.5.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.3 Mexico
6.5.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.4 Argentina
6.5.4.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.6 MEA
6.6.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.6.2 South Africa
6.6.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
Chapter 7 Digital Therapeutics Market - Competitive Analysis & Company Profiles
7.1 Market Participation Categorization
7.1.1 Market Leaders
7.1.1.1 Company market position/share analysis, 2020
7.1.2 Innovators
7.2 Major Deals & Strategic Alliances Analysis
7.2.1 List Of private companies
7.3 Company Profiles
7.3.1 Omada Health, Inc.
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic initiatives
7.3.2 WellDoc Inc.
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic initiatives
7.3.3 2 Morrow, Inc.
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Livongo Health
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic initiatives
7.3.5 Propeller Health
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Twinehealth
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Canary Health, Inc.
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Mango Health, Inc.
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Noom Health, Inc.
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Pear Therapeutics
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic initiatives



List of Tables



Table 1. List of Abbreviations
Table 2. Factors used in segment share estimation
Table 3. List of secondary data sources
Table 4. List of emerging companies
Table 5. North America digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 6. North America digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 7. North America digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 8. U.S. digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 9. U.S. digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 10. Canada digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 11. Canada digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 12. Europe digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 13. Europe digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 14. Europe digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 15. Germany digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 16. Germany digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 17. U.K. digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 18. U.K. digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 19. France digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 20. France digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 21. Italy digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 22. Italy digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 23. Spain digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 24. Spain digital therapeutics market, by end-use, 2016 - 2028(USD Million
Table 25. Asia Pacific digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 26. Asia Pacific digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 27. Asia Pacific digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 28. China digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 29. China digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 30. India digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 31. India digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 32. Japan digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 33. Japan digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 34. Latin America digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 35. Latin America digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 36. Latin America digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 37. Brazil digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 38. Brazil digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 39. Mexico digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 40. Mexico digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 41. Argentina digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 42. Argentina digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 43. MEA digital therapeutics market, by country, 2016 - 2028 (USD Million)
Table 44. MEA digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 45. MEA digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 46. South Africa digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 47. South Africa digital therapeutics market, by end-use, 2016 - 2028 (USD Million)
Table 48. Saudi Arabia digital therapeutics market, by application, 2016 - 2028 (USD Million)
Table 49. Saudi Arabia digital therapeutics market, by end-use, 2016 - 2028 (USD Million)